Boston Scientific Closes Acquisition of Axonics, Inc.
Boston Scientific Closes Acquisition of Axonics, Inc. Boston Scientific Closes Acquisition of Axonics, Inc. PR Newswire MARLBOROUGH, Mass., Nov. 15, 2024 MARLBOROUGH, Mass., Nov. 15, 2024...
PR Newswire·10mo ago
More News
Axonics Reports Third Quarter 2024 Financial Results
Axonics, Inc. (Nasdaq: AXNX), a medical technology company that develops, manufactures and commercializes innovative and minimally invasive products to treat bladder and bowel dysfunction, today...
Business Wire·10mo ago
Axonics Shares Fall Despite Australia's Approval for R20 SNM Device
Axonics, Inc. (NASDAQ: AXNX) has received regulatory approval from the Therapeutic Goods Administration to market its R20 rechargeable sacral neuromodulation (SNM) system in Australia.
read more...
Benzinga·1y ago
Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable SNM System in Australia
Axonics, Inc. (Nasdaq: AXNX) today announced that it has received regulatory approval from the Therapeutic Goods Administration (TGA) for marketing the Axonics R20 rechargeable sacral neuromodulation...
Business Wire·1y ago
Axonics Prevails in Patent Infringement Lawsuit with Medtronic
Axonics, Inc. (Nasdaq: AXNX) today announced that the jury has returned a unanimous verdict in the patent infringement lawsuit brought by Medtronic against Axonics in U.S. District Court for the...
Business Wire·1y ago
Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia
Axonics, Inc. (Nasdaq: AXNX) today announced that it has received regulatory approval from the Therapeutic Goods Administration (TGA) for marketing the Axonics F15 recharge-free sacral...
Business Wire·1y ago
Axonics Reports First Quarter 2024 Financial Results
Axonics, Inc. (Nasdaq: AXNX), a medical technology company that develops and commercializes innovative and minimally invasive products to treat bladder and bowel dysfunction, today reported financial...
Business Wire·1y ago
Noteworthy Thursday Option Activity: AXNX, ABBV, ROKU
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Axonics Inc (AXNX), where a total of 5,694 contracts have traded so far, representing...
Stock Options Channel·1y ago
Boston Scientific/Axonics merger to close in 2H24 as FTC seeks more info
Boston Scientific/Axonics merger to close in 2H24 as FTC seeks more info...
SeekingAlpha.com: All News·1y ago
Axonics (AXNX, $69.17) RSI Indicator left the overbought zone on April 01, 2024
This is a signal that AXNX's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...